Reply to: “Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor–based downstaging for hepatocellular carcinoma”: Revisiting rejection after immune checkpoint inhibitor exposure prior to liver transplantation for hepatocellular carcinoma
Reply to: “Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor–based downstaging for hepatocellular carcinoma”: Revisiting rejection after immune checkpoint inhibitor exposure prior to liver transplantation for hepatocellular carcinoma. // Journal of Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S0168827826027492?dgcid=rss_sd_all
Reply to: “Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor–based downstaging for hepatocellular carcinoma”: Revisiting rejection after immune checkpoint inhibitor exposure prior to liver transplantation for hepatocellular carcinoma. Journal of Hepatology. https://www.sciencedirect.com/science/article/pii/S0168827826027492?dgcid=rss_sd_all
“Reply to: “Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor–based downstaging for hepatocellular carcinoma”: Revisiting rejection after immune checkpoint inhibitor exposure prior to liver transplantation for hepatocellular carcinoma.” Journal of Hepatology.
@article{article53484,
title = {Reply to: “Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor–based downstaging for hepatocellular carcinoma”: Revisiting rejection after immune checkpoint inhibitor exposure prior to liver transplantation for hepatocellular carcinoma},
journal = {Journal of Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S0168827826027492?dgcid=rss_sd_all}
}